Biogen Idec (Nasdaq: BIIB) announced the appointment of Adam M. Koppel, M.D., Ph.D., as senior vice president and chief strategy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE